Ligand Pharmaceuticals Incorporated (FRA:LGDN)
153.00
-4.00 (-2.55%)
Last updated: Feb 20, 2026, 3:49 PM CET
35.40% (1Y)
| Market Cap | 3.07B +44.5% |
| Revenue (ttm) | 214.13M +64.8% |
| Net Income | 41.41M +7.4% |
| EPS | 2.12 +0.8% |
| Shares Out | n/a |
| PE Ratio | 74.23 |
| Forward PE | 22.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 3 |
| Open | 157.00 |
| Previous Close | 157.00 |
| Day's Range | 153.00 - 157.00 |
| 52-Week Range | 86.00 - 181.00 |
| Beta | n/a |
| RSI | 42.53 |
| Earnings Date | Feb 11, 2026 |